Second Quarter 2025 Results Key Financial Results Revenue: US$483.4m (up 4.3% from ...

First Quarter 2026 Results Key Financial Results Revenue: US$304.9m (up 15% from ...

Key Points Earnings per share (Non-GAAP) were $0.94 in Q2 2025 beating the analyst estimate by 9.3% (non-GAAP) and the company exceeded its non-GAAP EPS outlook by $0.08. Net sales (GAAP) reached ...

Key Points Earnings per share (GAAP) in Q2 2025 exceeded expectations, rising to $1.68 versus the analyst estimate of $1.47, and increasing 265.2% year-over-year. Net interest income on a fully ...

Q2 2025 Earnings Call Transcript August 1, 2025 Fortis Inc. beats earnings expectations. Reported EPS is $0.558, expectations ...

Q2 2025 Earnings Call Transcript August 1, 2025 IRadimed Corporation reports earnings inline with expectations. Reported EPS ...

Management reaffirmed 2025 operating earnings per share guidance of $3.28 to $3.52, with a midpoint of $3.40. Ridge stated, "I'm highly confident in our ability to deliver on our financial plan, ...

The Campbell's Company offers value after a 30% drop, with strong dividends and snack-driven growth potential for long-term ...

Analysts estimate that BioNTech will report an earnings per share (EPS) of $-1.31. The market awaits BioNTech's announcement, ...

Analysts anticipate Biomarin Pharmaceutical to report an earnings per share (EPS) of $0.93. The market awaits Biomarin ...

Operator: Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today.

Operator: Good morning, and welcome to the Dorian LPG First Quarter 2026 Earnings Conference Call. [Operator Instructions] As ...